Calcitonin gene-related peptide-targeting drugs and Raynaud’s phenomenon: a real-world potential safety signal from the WHO pharmacovigilance database

BACKGROUND: Migraine is responsible for significant disability and societal burden. Recently, drugs targeting the calcitonin gene-related peptide (CGRP) pathway raised new hopes. CGRP, a potent vasodilator, plays a key role in the pathogenesis of migraine attacks. The deficiency of CGRP is involved...

Descripción completa

Detalles Bibliográficos
Autores principales: Gérard, Alexandre O., Merino, Diane, Van Obberghen, Elise K., Rocher, Fanny, Destere, Alexandre, Lantéri-Minet, Michel, Drici, Milou-Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066820/
https://www.ncbi.nlm.nih.gov/pubmed/35505285
http://dx.doi.org/10.1186/s10194-022-01424-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066820/
https://www.ncbi.nlm.nih.gov/pubmed/35505285
http://dx.doi.org/10.1186/s10194-022-01424-w

Ejemplares similares